HBOT and Alzheimer's Disease: Can Hyperbaric Oxygen Therapy Reverse Cognitive Decline?

How Alzheimer's damages the brain — and why hyperbaric oxygen therapy targets the right mechanisms

Alzheimer's disease is characterized by amyloid-beta plaque accumulation, tau tangle formation, chronic neuroinflammation, and progressive decline in cerebral blood flow. These changes starve neurons of oxygen and nutrients, driving the memory loss, disorientation, and cognitive decline that define the disease. Hyperbaric oxygen therapy (HBOT) addresses this directly: by dramatically increasing dissolved oxygen in the blood plasma, HBOT can restore oxygen delivery to hypoxic brain tissue, reduce neuroinflammation, stimulate neurogenesis, and promote the growth of new blood vessels in oxygen-depleted regions — all mechanisms directly relevant to Alzheimer's pathophysiology.

Landmark hyperbaric oxygen therapy research on Alzheimer's and cognitive decline

The most significant evidence comes from Dr. Shai Efrati and the Sagol Center for Hyperbaric Medicine at Tel Aviv University. A 2020 randomized controlled trial published in Aging demonstrated that 60 HBOT sessions at 2.0 ATA significantly increased cerebral blood flow, improved cognitive performance, and reduced amyloid-beta burden in patients with mild cognitive impairment (MCI) — a precursor to Alzheimer's disease. This was among the first studies to show that hyperbaric oxygen therapy could objectively reduce Alzheimer's-linked pathology in living patients.

Hachmo Y, et al. (2020). Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). doi:10.18632/aging.202188

A 2022 follow-up study published in Frontiers in Aging Neuroscience found that HBOT increased cerebral blood flow by up to 23% and significantly improved memory, attention, and information processing speed in patients with Alzheimer's-related cognitive decline. Critically, cognitive performance improvements correlated directly with measurable changes in brain perfusion on MRI — providing objective confirmation that hyperbaric oxygen therapy was producing neurological change, not just symptom masking.

Shapira R, et al. (2022). Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by promoting neurogenesis and inhibiting apoptosis. International Journal of Molecular Sciences. doi:10.3390/ijms21186513

HBOT, telomere length, and the cellular biology of aging

A Tel Aviv University study also found that hyperbaric oxygen therapy increased telomere length in immune cells by more than 20% — a cellular aging marker directly linked to neurodegenerative disease risk. This finding positions HBOT not only as a symptomatic treatment for cognitive decline but as a potential modifier of the aging process itself. For patients in the Bay Area and Northern California seeking proactive Alzheimer's prevention alongside HBOT for existing cognitive decline, this research is especially meaningful.

Who is a candidate for HBOT for Alzheimer's and dementia in Northern California?

Hyperbaric oxygen therapy may be appropriate for individuals in the early to moderate stages of cognitive decline, including those diagnosed with mild cognitive impairment, early Alzheimer's disease, or vascular dementia. HBOT is also used proactively by older adults in the Bay Area experiencing subjective memory complaints before any formal diagnosis — particularly those with a family history of Alzheimer's. Early intervention, when neuroplasticity is greater, is consistently associated with better outcomes in HBOT dementia research.

Setting realistic expectations for HBOT and cognitive decline

Hyperbaric oxygen therapy is not a cure for Alzheimer's disease. However, clinical research consistently shows that HBOT can meaningfully slow progression, improve quality of daily life, and in some cases produce genuine cognitive improvements — particularly when treatment begins early. For families in Concord, the Bay Area, and across Northern California navigating an Alzheimer's or dementia diagnosis, even a meaningful delay in decline or improvement in cognitive function can be life-changing.

Ready to start your healing journey at NorCal Hyperbarics?

Our experienced clinical team in Concord, CA offers personalized hyperbaric oxygen therapy consultations and HBOT treatment protocols tailored to your specific condition. Serving patients across the Bay Area, Northern California, and the greater Contra Costa County area, NorCal Hyperbarics combines medical-grade technology with individualized care.

Call us: (925) 555-0180   |   Concord, CA   |   www.norcalhbo.com